No Data
No Data
ImmunoPrecise Antibodies Advances in Cancer Therapy Development
$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies
ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation
Express News | ImmunoPrecise Highlights Publication Of Mayo Clinic Scientist-Led Research In BioRxiv And Autophagy Titled 'Development and Characterization of Phospho-Ubiquitin Antibodies to Monitor PINK1-PRKN Signaling in Cells and Tissue'
ImmunoPrecise Advances Anti-Aging Research With Mayo Clinic Study, Poised to Tap Into $81 Billion Market With AI Technology
ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024
No Data
No Data